The FDA may move to allow the temporary importation of intravenous fluids and related products from overseas manufacturing sites to address critical shortages exacerbated by Hurricane Helene, the agency told Becker’s Oct. 9.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
